The druggability of SH2 domains unmasked

被引：0
|
作者：
Oliver Hantschel
机构：
[1] Philipps-University of Marburg,Institute of Physiological Chemistry
来源：
Nature Chemical Biology | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Developing inhibitors for SH2 domains is challenging due to their shallow pockets and highly charged ligands. Structure-guided drug design has enabled the discovery of a cell-permeable covalent inhibitor of the SOCS2 SH2 domain, a key regulator of cytokine signaling pathways.
引用
收藏
页码：271 / 272
页数：1
相关论文
共 50 条
  • [1] The druggability of SH2 domains unmasked
    Hantschel, Oliver
    NATURE CHEMICAL BIOLOGY, 2024, 20 (03) : 271 - 272
  • [2] SH2 AND SH3 DOMAINS
    PAWSON, T
    SCHLESSINGER, J
    CURRENT BIOLOGY, 1993, 3 (07) : 434 - 442
  • [3] Dual specificity of SH2 domains
    Kirsty Minton
    Nature Reviews Molecular Cell Biology, 2016, 17 : 266 - 266
  • [4] STRUCTURES OF SH2 AND SH3 DOMAINS
    KURIYAN, J
    COWBURN, D
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 1993, 3 (06) : 828 - 837
  • [5] Functions of SH2 and SH3 domains
    Mayer, BJ
    Gupta, R
    PROTEIN MODULES IN SIGNAL TRANSDUCTION, 1998, 228 : 1 - 22
  • [6] STRUCTURE AND FUNCTION OF SH2 DOMAINS
    MARENGERE, LEM
    PAWSON, T
    JOURNAL OF CELL SCIENCE, 1994, : 97 - 104
  • [7] SH2 domains - A question of independence
    Wandless, TJ
    CURRENT BIOLOGY, 1996, 6 (02) : 125 - 127
  • [8] Molecular recognition by SH2 domains
    Bradshaw, JM
    Waksman, G
    PROTEIN MODULES AND PROTEIN-PROTEIN INTERACTIONS, 2003, 61 : 161 - 210
  • [9] Interactions between SH2 and SH3 domains
    Vihinen, M
    Smith, CIE
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 242 (02) : 351 - 356
  • [10] SH2 SH3 - EXPLORATION OF NEW DOMAINS
    MOORE, B
    SEROUSSI, G
    JOCHIM, B
    M S-MEDECINE SCIENCES, 1993, 9 (6-7): : 788 - 790
12345